When I tell you that insiders are back and buying in a big way, I’m not lying.
One of the newest picks I’ve recommended to my members is a tiny biotech company that’s developing treatments for orphan diseases through the use of soluble guanylate cyclase.
I’ll be honest…
I have no idea what that means.
But guess who does?
The CEO and founder… who just loaded the boat with $2,430,000 worth of stock.
What’s more is that the investment came out of nowhere with no obvious public news surrounding the company.
Check out the video above for more details on this opportunity that I believe has the potential to move several hundred percent…